Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 81

Similar articles for PubMed (Select 10851047)

1.

STAT signaling in head and neck cancer.

Song JI, Grandis JR.

Oncogene. 2000 May 15;19(21):2489-95. Review.

2.
3.

STAT3 activation abrogates growth factor dependence and contributes to head and neck squamous cell carcinoma tumor growth in vivo.

Kijima T, Niwa H, Steinman RA, Drenning SD, Gooding WE, Wentzel AL, Xi S, Grandis JR.

Cell Growth Differ. 2002 Aug;13(8):355-62.

4.

Epidermal growth factor receptor--mediated stat3 signaling blocks apoptosis in head and neck cancer.

Rubin Grandis J, Zeng Q, Drenning SD.

Laryngoscope. 2000 May;110(5 Pt 1):868-74.

PMID:
10807365
6.

Requirement of Stat3 but not Stat1 activation for epidermal growth factor receptor- mediated cell growth In vitro.

Grandis JR, Drenning SD, Chakraborty A, Zhou MY, Zeng Q, Pitt AS, Tweardy DJ.

J Clin Invest. 1998 Oct 1;102(7):1385-92.

7.

Constitutive activation of Stat3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo.

Grandis JR, Drenning SD, Zeng Q, Watkins SC, Melhem MF, Endo S, Johnson DE, Huang L, He Y, Kim JD.

Proc Natl Acad Sci U S A. 2000 Apr 11;97(8):4227-32.

8.

Differential function of STAT5 isoforms in head and neck cancer growth control.

Leong PL, Xi S, Drenning SD, Dyer KF, Wentzel AL, Lerner EC, Smithgall TE, Grandis JR.

Oncogene. 2002 Apr 25;21(18):2846-53.

9.

STAT 3 activation in head and neck squamous cell carcinomas is controlled by the EGFR.

Hambek M, Baghi M, Strebhardt K, May A, Adunka O, Gstöttner W, Knecht R.

Anticancer Res. 2004 Nov-Dec;24(6):3881-6. Erratum in: Anticancer Res. 2005 Jan-Feb;25(1b):681. Strebhard, Klaus [corrected to Strebhardt, Klaus].

13.

Src kinases mediate STAT growth pathways in squamous cell carcinoma of the head and neck.

Xi S, Zhang Q, Dyer KF, Lerner EC, Smithgall TE, Gooding WE, Kamens J, Grandis JR.

J Biol Chem. 2003 Aug 22;278(34):31574-83. Epub 2003 May 27.

14.
15.

The roles of JNK1 and Stat3 in the response of head and neck cancer cell lines to combined treatment with all-trans-retinoic acid and 5-fluorouracil.

Masuda M, Toh S, Koike K, Kuratomi Y, Suzui M, Deguchi A, Komiyama S, Weinstein IB.

Jpn J Cancer Res. 2002 Mar;93(3):329-39.

PMID:
11927016
16.
17.

Targeted inhibition of Stat3 with a decoy oligonucleotide abrogates head and neck cancer cell growth.

Leong PL, Andrews GA, Johnson DE, Dyer KF, Xi S, Mai JC, Robbins PD, Gadiparthi S, Burke NA, Watkins SF, Grandis JR.

Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):4138-43. Epub 2003 Mar 14.

18.
20.

Immunohistochemical analysis of phosphotyrosine signal transducer and activator of transcription 3 and epidermal growth factor receptor autocrine signaling pathways in head and neck cancers and metastatic lymph nodes.

Seethala RR, Gooding WE, Handler PN, Collins B, Zhang Q, Siegfried JM, Grandis JR.

Clin Cancer Res. 2008 Mar 1;14(5):1303-9. doi: 10.1158/1078-0432.CCR-07-1543. Erratum in: Clin Cancer Res. 2008 Apr 1;14(7):2247.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk